Delayed Onset Malignant Hyperthermia after Sevoflurane

Malignant hyperthermia is a hypermetabolic response to inhalation agents (such as halothane, sevoflurane, and desflurane), succinylcholine, vigorous exercise, and heat. Reactions develop more frequently in males than females (2 : 1). The classical signs of malignant hyperthermia are hyperthermia, ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Turhan, K. Sanem Cakar, Baytaş, Volkan, Batislam, Yeşim, Özatamer, Oya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683465/
https://www.ncbi.nlm.nih.gov/pubmed/23819066
http://dx.doi.org/10.1155/2013/712710
_version_ 1782273499797127168
author Turhan, K. Sanem Cakar
Baytaş, Volkan
Batislam, Yeşim
Özatamer, Oya
author_facet Turhan, K. Sanem Cakar
Baytaş, Volkan
Batislam, Yeşim
Özatamer, Oya
author_sort Turhan, K. Sanem Cakar
collection PubMed
description Malignant hyperthermia is a hypermetabolic response to inhalation agents (such as halothane, sevoflurane, and desflurane), succinylcholine, vigorous exercise, and heat. Reactions develop more frequently in males than females (2 : 1). The classical signs of malignant hyperthermia are hyperthermia, tachycardia, tachypnea, increased carbon dioxide production, increased oxygen consumption, acidosis, muscle rigidity and rhabdomyolysis. In this case report, we present a case of delayed onset malignant hyperthermia-like reaction after the second exposure to sevoflurane.
format Online
Article
Text
id pubmed-3683465
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-36834652013-07-01 Delayed Onset Malignant Hyperthermia after Sevoflurane Turhan, K. Sanem Cakar Baytaş, Volkan Batislam, Yeşim Özatamer, Oya Case Rep Anesthesiol Case Report Malignant hyperthermia is a hypermetabolic response to inhalation agents (such as halothane, sevoflurane, and desflurane), succinylcholine, vigorous exercise, and heat. Reactions develop more frequently in males than females (2 : 1). The classical signs of malignant hyperthermia are hyperthermia, tachycardia, tachypnea, increased carbon dioxide production, increased oxygen consumption, acidosis, muscle rigidity and rhabdomyolysis. In this case report, we present a case of delayed onset malignant hyperthermia-like reaction after the second exposure to sevoflurane. Hindawi Publishing Corporation 2013 2013-05-30 /pmc/articles/PMC3683465/ /pubmed/23819066 http://dx.doi.org/10.1155/2013/712710 Text en Copyright © 2013 K. Sanem Cakar Turhan et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Turhan, K. Sanem Cakar
Baytaş, Volkan
Batislam, Yeşim
Özatamer, Oya
Delayed Onset Malignant Hyperthermia after Sevoflurane
title Delayed Onset Malignant Hyperthermia after Sevoflurane
title_full Delayed Onset Malignant Hyperthermia after Sevoflurane
title_fullStr Delayed Onset Malignant Hyperthermia after Sevoflurane
title_full_unstemmed Delayed Onset Malignant Hyperthermia after Sevoflurane
title_short Delayed Onset Malignant Hyperthermia after Sevoflurane
title_sort delayed onset malignant hyperthermia after sevoflurane
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683465/
https://www.ncbi.nlm.nih.gov/pubmed/23819066
http://dx.doi.org/10.1155/2013/712710
work_keys_str_mv AT turhanksanemcakar delayedonsetmalignanthyperthermiaaftersevoflurane
AT baytasvolkan delayedonsetmalignanthyperthermiaaftersevoflurane
AT batislamyesim delayedonsetmalignanthyperthermiaaftersevoflurane
AT ozatameroya delayedonsetmalignanthyperthermiaaftersevoflurane

Ejemplares similares